Navigating the CKM Conundrum: An Integrated Approach to Cardiovascular,Kidney,and Metabolic Health

Abstract

Get full access to this article

View all access options for this article.

References

Agarwal

Filippatos

Pitt

, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43(6):474-484. doi:10.1093/eurheartj/ehab777

American Academy of Family Physicians (AAFP). The EveryONE Project: social needs screening tool. Accessed August 20, 2024. https://www.aafp.org/family-physician/patient-care/the-everyone-project/toolkit.html

American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024. Diabetes Care. 2024;47(suppl 1):S158-S178. doi:10.2337/dc24-S009

Centers for Medicare and Medicaid Services. The Accountable Health Communities Health-Related Social Needs Screening Tool. Accessed August 8, 2024. https://www.cms.gov/priori-ties/innovation/files/worksheets/ahcm-screeningtool.pdf

de Boer

Khunti

Sadusky

, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075-3090. doi:10.2337/dci22-0027

Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. doi:10.1016/S2213-8587(15)00291-0

Diao

Shi

Murthy

, et al. Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations. JAMA. 2024;332(12):989-1000. doi:10.1001/jama.2024.12537

The EMPA-KIDNEY Collaborative Group, Herrington

Staplin

, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127. doi:10.1056/NEJMoa2204233

Gold

Bunce

Cowburn

, et al. Adoption of social determinants of health EHR tools by community health centers. Ann Fam Med. 2018;16(5):399-407. doi:10.1370/afm.2275

10.

Grunvald

Shah

Hernaez

, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198-1225. doi:10.1053/j.gastro.2022.08.045

11.

Health Leads. The Health Leads Screening Toolkit. Health Leads. November 30, 2022. Accessed August 8, 2024. https://healthleadsusa.org/news-resources/the-health-leads-screening-toolkit/

12.

Hoffberg

Valu

. Overcoming obstacles to social determinants of health. June 9, 2020. Accessed August 8, 2024. https://www.himss.org/resources/overcoming-obstacles-social-determinants-health

13.

Khan

Coresh

Pencina

, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982-2004. doi:10.1161/CIR.0000000000001191

14.

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney int. 2022;102(5S):S1-S127. doi:10.1016/j.kint.2022.06.008

15.

Kosmas

Bousvarou

Kostara

Papakonstantinou

Salamou

Guzman

Insulin resistance and cardiovascular disease. J int Med Res. 2023;51(3):3000605231164548. doi:10.1177/03000605231164548

16.

Lloyd-Jones

Allen

Anderson

CAM

, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-e43. doi:10.1161/CIR.0000000000001078

17.

Maddox

Januzzi

Allen

, et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024;83(15):1444-1488. doi:10.1016/j.jacc.2023.12.024

18.

Ndumele

Rangaswami

Chow

, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606-1635. doi:10.1161/CIR.0000000000001184

19.

NORC at the University of Chicago, American Health Information Management Association. Social determinants of health data: survey results on the collection, integration, and use. Accessed August 8, 2024. https://www.ahima.org/media/03dbonub/ahima_sdoh-data-report.pdf

20.

Office of Disease Prevention and Health Promotion. Social determinants of health. Accessed August 1, 2024. https://health.gov/healthypeople/priority-areas/social-determinants-health

21.

Rodriguez

Ryan

Dickinson

Phan

. Improving quality outcomes: the value of diabetes care and education specialists. Clin Diabetes Publ Am Diabetes Assoc. 2022;40(3):356-365. doi:10.2337/cd21-0089

22.

Sinha

Papamargaritis

Sargeant

Davies

MJ.

Efficacy and safety of tirzepatide in type 2 diabetes and obesity management. J Obes Metab Syndr. 2023;32(1):25-45. doi:10.7570/jomes22067